InvestorsHub Logo
Followers 70
Posts 2498
Boards Moderated 0
Alias Born 08/11/2017

Re: None

Friday, 06/21/2019 3:05:24 PM

Friday, June 21, 2019 3:05:24 PM

Post# of 71147
LAHO! GSCG...New Stem Cell Therapy for Neurodegenerative Disease

..Global Stem Cells Group Inc. (GCSG) plans to collaborate with regenerative medicine specialist Burton Feinerman, M.D., to offer new stem cell therapies that combine adult stem cells derived from adipose tissue, bone marrow and peripheral blood with differentiated cells and transference factors, using patented protocols developed by Feinerman.

..Feinerman is a physician and research scientist specializing in stem cell therapies, ant-aging medicine and gene therapies to treat a variety of conditions and diseases. He is a member of the GSCG Advisory Board.

https://www.odtmag.com/contents/view_breaking-news/2015-08-26/global-stem-cells-group-to-develop-new-stem-cell-therapy-for-neurodegenerative-disease/48608

Burton Feinerman, M.D. is a stem cell physican and research scientist specializing in anti-aging treatments. He is president of StemCellRegenMed, based in Miami, Florida.

Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases.
He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.

Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.

http://www.stemcellsgroup.com/advisory-board/




$LAHO GSCG

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.